Work

Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics

Year: 2026

Type: article

Source: Molecular Psychiatry

DOI: 10.1038/s41380-026-03506-6

Authors: Ming-Fen Ho, Cheng Zhang, Brandon J. Coombes, Joanna M. Biernacka, Paul E. Croarkin, Tyler S. Oesterle, Victor M. Karpyak, Hu Li, Richard M. Weinshilboum

Institution: Mayo Clinic

Language: English

Topic: Substance Abuse Treatment and Outcomes

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Brain and Behavior Research Foundation, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse

Awards: Acamprosate pharmacogenomics: iPSC based model of alcohol use disorder, G4736522732, G4960006704, G5883652275, G8214871566, Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics, Single cell multi-omics of iPSC-derived brain organoids from patients with opioid use disorder: synthetic opioids as molecular probes

OpenAlex ID: W7131360710

FWCI:

Cites: 41

Cited by:

Related to: 10